US FDA extends review of Ascendis Pharma's therapy for children with dwarfism
Ascendis Pharma(US:ASND) Reuters·2025-11-25 23:21监管审批动态 - 美国食品药品监督管理局延长对Ascendis Pharma针对一种导致侏儒症的罕见遗传病儿童疗法的审查 [1]
Ascendis Pharma(US:ASND) Reuters·2025-11-25 23:21Ascendis Pharma(US:ASND) Reuters·2025-11-25 23:21